Page 1

Investor news Capital Markets Day 2021 Delivering sustained growth post coronavirus On Monday 27 September at 11:00 CET , Demant hosts a Capital Markets Day ( CMD ) in Copenhagen for inves tors and analysts , and the event will be open for both physical and virtual attendance . During the event , we will outline how we aim to deliver sustained growth and realise the potential for margin expansion that we see in all our business areas . We will also highlight the resilience of our business model and our ability to service users of today and tomorrow . The presentations and livestream will be available at our CMD microsite shortly before the event . Background In 2021 , Demant has seen very strong business momentum driven by Hearing Healthcare , which has performed excellently and has more than compensated for softening demand experienced by Communications . With the cur rent guidance , we are on track to deliver on our ambitious growth plans and to realise all - time high profits . The strong performance comes after a couple of years where the Group has gone through significant changes with the IT incident in September 2019 and coronavirus that started in the beginning of 2020. During this time , the Group has successfully launched new innovative products offering industry - leading audiology in Hearing Aids , transformed and accelerated the digital journey in Hearing Care and improved profitability , reinforced the position of Diagnos tics as market leader and positioned Hearing Implants well for the future with new products and access to the large US market for cochlear implants following pre - market approval by the FDA . At the same time , we have demerged our Sennheiser Communications joint venture and instead established EPOS as a player in the market for enter prise and gaming headsets , allowing us to address this highly attractive market more ambitiously than previously . We thus emerge from recent years ' significant changes as a stronger company , and we are set for strong financial results in 2021. Assuming that revenue will be at the midpoint of our current guidance range , this represents a compound annual growth rate of 10 % in local currencies in the ten years since 2012 , with 6 % organic growth and 4 % acquisitive growth . This successful track record over a long time period is a strong testament to our ability to deliver sustained growth , which we also aim to do in the coming years . ■ Demant Key messages from today's Capital Markets Day Under the heading of " Delivering sustained growth post coronavirus " , the key messages of today's Capital Markets Day will be : ■ 27 September 2021 ■ ■ In line with historical levels , we aim to generate revenue growth for the Group of 7-10 % p.a. in local currencies in the medium to long term . This comprises organic growth of 6-8 % p.a. supplemented by acquisitive growth from bolt - on acquisitions of 1-2 % p.a. We thus aim for both Hearing Healthcare and Communications to deliver organic growth above the estimated structural market growth rates of approx . 4 % ( unchanged ) and approx . 12 % ( previously 8-10 % ) p.a. , respectively . In the coming years , we expect pent - up demand to support volumes in the hearing aid market . Relative to nor mal expectations , we estimate that the total shortfall in units sold during the pandemic amounts to around 3.7 million , and we consider it probable that a significant share of these units will come back as pent - up demand in the coming years . We continue to see potential for margin expansion in all business areas with scope for incremental improve ments in Hearing Aids , Hearing Care and Diagnostics and scope for transformative improvements in Hearing Implants and Communications , as we expand these businesses in the coming years . Demant A / S Kongebakken 9 2765 Smørum We remain deeply focused on innovation and consider scale key for ensuring long - term success . In particular , we focus on remaining leaders in audiological performance across our business areas as we believe that such leadership will also prove to be a competitive advantage in the future . +45 3917 7300 info@demant.com www.demant.com CVR 71186911 Page 1 of 3